SI-BONE, Inc. (NASDAQ:SIBN) CEO Laura Francis Sells 10,048 Shares

SI-BONE, Inc. (NASDAQ:SIBN) CEO Laura Francis sold 10,048 shares of the stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $12.58, for a total value of $126,403.84. Following the completion of the transaction, the chief executive officer now directly owns 482,875 shares in the company, valued at approximately $6,074,567.50. This trade represents a 2.04 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

SI-BONE Price Performance

Shares of SIBN stock opened at $12.31 on Friday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 7.22 and a current ratio of 8.25. The stock’s 50-day simple moving average is $13.79 and its 200-day simple moving average is $14.23. The firm has a market capitalization of $516.24 million, a price-to-earnings ratio of -13.38 and a beta of 1.22. SI-BONE, Inc. has a fifty-two week low of $11.70 and a fifty-two week high of $21.70.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the company. Rhumbline Advisers boosted its holdings in SI-BONE by 1.5% in the 2nd quarter. Rhumbline Advisers now owns 59,419 shares of the company’s stock valued at $768,000 after purchasing an additional 852 shares during the last quarter. Arizona State Retirement System lifted its holdings in SI-BONE by 9.0% in the second quarter. Arizona State Retirement System now owns 10,921 shares of the company’s stock valued at $141,000 after acquiring an additional 903 shares during the last quarter. The Manufacturers Life Insurance Company grew its stake in shares of SI-BONE by 7.5% in the second quarter. The Manufacturers Life Insurance Company now owns 15,880 shares of the company’s stock valued at $205,000 after buying an additional 1,105 shares in the last quarter. FMR LLC raised its holdings in shares of SI-BONE by 103.6% in the 3rd quarter. FMR LLC now owns 2,354 shares of the company’s stock valued at $33,000 after buying an additional 1,198 shares during the period. Finally, Price T Rowe Associates Inc. MD lifted its stake in SI-BONE by 7.2% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 20,494 shares of the company’s stock worth $336,000 after acquiring an additional 1,372 shares in the last quarter. Institutional investors and hedge funds own 98.11% of the company’s stock.

Wall Street Analyst Weigh In

SIBN has been the subject of several recent research reports. Morgan Stanley decreased their price objective on SI-BONE from $21.00 to $19.00 and set an “overweight” rating for the company in a report on Tuesday, August 6th. Needham & Company LLC reissued a “buy” rating and set a $19.00 price objective on shares of SI-BONE in a report on Wednesday. Finally, Truist Financial boosted their price target on SI-BONE from $16.00 to $18.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $23.00.

About SI-BONE

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.